New diabetes drug enters human testing – could it replace insulin?
NCT ID NCT06280703
First seen Oct 31, 2025 · Last updated May 01, 2026 · Updated 26 times
Summary
This early-phase study tests a new medicine called LY3938577 in healthy volunteers and people with type 1 diabetes. The main goals are to check how the drug moves through the body, its safety, and any side effects. Later parts of the study will compare its blood sugar-lowering effects to a standard insulin. About 118 participants will take part across four groups, with the study lasting up to 13 weeks.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 1 DIABETES MELLITUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Profil Institut für Stoffwechselforschung
RECRUITINGNeuss, 41460, Germany
Contact Phone: •••-•••-••••
Contact
Conditions
Explore the condition pages connected to this study.